Foley represented RXBAR in its acquisition by Kellogg Company in a $600 million deal.
Chicago Bar Company d/b/a RXBAR, maker of the popular protein bar RXBAR, will continue to operate as an independent business headquartered in Chicago.
Foley & Lardner has represented RXBAR since 2013 and served as its outside general counsel in addition to advising on the sale. “RXBAR is a great example of how Foley works with growth companies and helps them as their business scales,” said partner Chris Cain, who led the Foley M&A team along with Chris Rasmussen.
People
Related News
June 6, 2025
In the News
David Rosen Comments on FDA, Compounder Conflict Over Drug Shortages
Foley & Lardner LLP partner David Rosen highlighted the U.S. Food and Drug Administration's drug shortage list in the BioSpace article, "Post-Chevron Legal Battles: Three Key Cases to Watch."
June 6, 2025
In the News
Louis Lehot Comments on Crypto Company IPO – 'Definitely a home run'
Foley & Lardner LLP partner Louis Lehot commented on the initial public offering of stablecoin issuer Circle in the Law360 article, "Circle's Smash IPO Could Pave Way For More Crypto Listings."
June 5, 2025
In the News
Michael Bennett and Zack Flagel Explore Pro Tennis Antitrust Battle
Foley & Lardner LLP attorneys Michael Bennett and Zack Flagel assess the antitrust litigation embroiling professional tennis in their LawInSport article, "Break(ing) Point? The Antitrust Battle that Could Transform Professional Tennis."